题目内容
（请给出正确答案）
The recent Genome Wars were symbolic of _____.
［A］ the enthusiasm in scientific research
［B］ the significance of the space race
［C］ the public versus private conflict
［D］ the prospect of the completion of DNA sequence
简答题官方参考答案
（由简答题聘请的专业题库老师提供的解答）
更多“The recent Genome Wars were symbolic of _____.［A］ the enthusiasm in scientific rese”相关的问题
From the last paragraph, we learn that
A．employers could specify the ages of people they want to hire in the past.
B．all employers recruited workers through advertisement in the past.
C．legislation prohibiting discrimination can't free old workers from age discrimination.
D．the recent proposed congressional legislation is ineffective.
Part A
Directions: Read the following four texts. Answer the questions below each text by choosing A, B, C or D. (40 points)
It was the biggest scientific grudge match since the space race. The Genome Wars had everything: two groups with appealing leaders ready to fight in a scientific dead heat, pushing the limits of technology and rhetoric as they battled to become the first to read every last one of the 3 billion DNA "letters" in the human body. The scientific importance of the work is unquestionable. The completed DNA sequence is expected to give scientists unprecedented insights into the workings of the human body, revolutionizing medicine and biology. But the race itself, between the government's Human Genome Project and Rockville, Md., biotechnology company Celera Genomics, was at least partly symbolic, the public/private conflict played out in a genetic lab.
Now the race is over. After years of public attacks and several failed attempts at reconciliation, the two sides are taking a step toward a period of calm. HOP head Francis Collins (and Ari Patrinos of the Department of Energy, an important ally on the government side) and Craig Venter, the founder of Celera, agreed to hold a joint press conference in Washington this Monday to declare that the race was over (sort of), that both sides had won (kind of) and that the hostilities were resolved (for the time being).
No one is exactly sure how things will be different now. Neither side will be turning off its sequencing machines any time soon—the "finish lines" each has crossed are largely arbitrary points, "first drafts" rather than the definitive version. And while the joint announcement brings the former Genome Warriors closer together than they've been in years, insiders say I that future agreements are more likely to take the form. of coordination, rather than outright collaboration.
The conflict blew up this February when Britain's Welcome Trust, an HGP participant, released a confidential letter to Celera outlining the HGP's complaints. Venter called the move "a lowlife thing to do", but by spring, there were the first signs of a thaw. "The attacks and nastiness are bad for science and our investors", Venter told Newsweek in March, "and fighting back is probably not helpful". At a cancer meeting earlier this month, Venter and Collins praised each other's approaches, and expressed hope that all of the scientists involved in sequencing the human genome would be able to share the credit By late last week, that hope was becoming a reality as details for Monday's joint announcement were hammered out. Scientists in both camps welcomed an end to the hostilities. "If this ends the horse race, science wins". With their difference behind them, or at least set aside, the scientists should now be able to get down to the interesting stuff, figuring how to make use of all that data.
The recent Genome Wars were symbolic of
A．the enthusiasm in scientific research.
B．the significance of the space race.
C．the public versus private conflict.
D．the prospect of the completion of DNA sequene.
Now the industry is convinced that a third revolution is under way: the convergence of biology and engineering. A recent report from the Massachusetts Institute of Technology says that physical sciences have already been transformed by their adoption of information technology, advanced materials, imaging, nanotechnolugy and sophisticated modelling and simulation. Phillip Sharp, a Nobel prize-winner at that university, believes that those tools are about to be brought to bear on biology too.
But the chances are that this will take time, and turn out to be more of a reformation than a revolution. The conventional health-care systems of the rich world may resist new technologies even as poor countries leapfrog ahead. There is already a backlash against genomics, which has been oversold to consumers as a deterministic science. And given soaring health-care costs, insurers and health systems may not want to adopt new technologies unless inventors can show conclusively that they will produce better outcomes and offer value for money.
If these obstacles can be overcome, then the biggest winner will be the patient. In the past medicine has taken a paternalistic stance, with the all-knowing physician dispensing wisdom from on high, but that is becoming increasingly untenable. Digitisation promises to connect doctors not only to everything they need to know about their patients but also to other doctors who have treated similar disorders. That essential reform. will enable many other big technological changes to be introduced.
Just as important, it can make that information available to the patients too, empowering them to play a bigger part in managing their own health affairs. This is controversial, and with good reason. Many doctors, and some patients, reckon they lack the knowledge to make informed decisions. But patients actually know a great deal about many diseases, especially chronic ones like diabetes and heart problems with which they often live for many years. The best way to deal with those is for individuals to take more responsibility for their own health and prevent problems before they require costly hospital visits. That means putting electronic health records directly into patients’ hands.
Which of the following might be true about modern biology according to the first paragraph？
A．The molecular and cell structure are found during the first revolution.
B．Scientists sequenced the human genome half a century ago.
C．Scientists have completely understood the mystery of DNA
D．The origins of some diseases have been found in the second revolution.
China is fast applying the latest life-science techniques learned from the West to aggressively pursue genome research. It's establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China. And in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.
For the moment, the cooperation exists mostly with Europe and the U.S. But Asia's other biotech leaders, Japan, Singapore and Korea, also are recognizing China's potential as an attractive low-cost base to conduct research. These partnerships——and China's advancement in the field of biotechnology——could help benefit the rest of Asia: China's rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population——and those of other Asian countries——can afford.
There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safely Protocol, which should mean adherence to global standards governing the conduct of field trials. But some observers are skeptical. "The regulations look good, but I haven't met one scientist who believes they are being fully adhered to," says a European science analyst.
If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab test are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China.
The mouse on display is most significant in that ______.
A．it has an ear in the shape of a human ear
B．it is unusually small and ugly as a star
C．it is the focus of the media at the exhibition
D．it indicates China's progress in biotechnology
China is fast applying the latest life-science techniques learned from the West m aggressively pursue genome research. It's establishing its own centers of technical excellence to build a scientific base to compete directly with the United States and Europe. With a plentiful supply of smart young scientists at home and lots of interest abroad biotechnology is on the brink of a boom in China and in the view of foreign scientists, Beijing is playing a clever hand, maximizing the opportunities open to them.
For the moment, the cooperation exists mostly with Europe and the U. S. But Asia's other biotech leaders, Japan, Singapore and Korea, also are recognizing China's potential as an attractive low-cost base to conduct research. These partnerships--and China's advancement in the field of biotechnology--could help benefit the rest of Asia: China's rapid progress in improving crop yields will address food-security concerns in the region. In addition, China is more likely to focus on developing cheap technology that its predominantly poor population--and those of other Asian countries--can afford.
There remain, however, serious barriers to the development of a strong biotech industry. Among them are a poor domestic legal framework, weak enforcement of intellectual-property rights and loose adherence to international standards. China is a signatory of the International Bio Safety Protocol, which should mean adherence to global standards governing the conduct of field trims. But some observers are skeptical. "The regulations look good, but I haven't met one scientist who believes they are being fully adhered to," says a European science analyst.
If shortcuts are taken, then some of the recent scientific achievements trumpeted in the official press may never make it to market. But no matter how strict lab tests are, other problems lie in wait. For example, there is a number of tasks it would take years to fulfill in the patents office, says one lawyer, leaving innovators with little protection if they take a product to market in China.
The mouse on display is most significant in that ______.
A．it has an ear in the shape of a human ear
B．it is unusually small and ugly as a star
C．it is the focus of. the media at the exhibition
D．it indicates China's progress in biotechnology
China took part in the Human Genome Project in 1993.
A．Y
B．N
C．NG
A．easy
B．difficult
C．independent of the size of genome
D．not possible
警告：系统检测到您的账号存在安全风险
为了保护您的账号安全，请在“简答题”公众号进行验证，点击“官网服务”-“账号验证”后输入验证码“”完成验证，验证成功后方可继续查看答案！
